Technical Analysis for MLND - Millendo Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 6.84 -1.87% -0.13
MLND closed down 1.87 percent on Friday, September 20, 2019, on 4.14 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical MLND trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Weak + Overbought Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Weak, Overbought and Reversal Signs Reversal 0.00%
Overbought Stochastic Strength 0.00%
Shooting Star Candlestick Bearish -1.87%

Older signals for MLND ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.
Organ Systems Endocrine System Late Stage Biopharmaceutical Cushing's Syndrome Adrenal Gland Disorders Congenital Adrenal Hyperplasia Endocrine Diseases Prader Willi Syndrome
Is MLND a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.34
52 Week Low 4.56
Average Volume 31,269
200-Day Moving Average 11.4849
50-Day Moving Average 7.8118
20-Day Moving Average 6.0605
10-Day Moving Average 6.269
Average True Range 0.5046
ADX 31.71
+DI 31.6289
-DI 23.8384
Chandelier Exit (Long, 3 ATRs ) 5.9862
Chandelier Exit (Short, 3 ATRs ) 6.0738
Upper Bollinger Band 7.6918
Lower Bollinger Band 4.4292
Percent B (%b) 0.74
BandWidth 53.833842
MACD Line -0.2664
MACD Signal Line -0.5863
MACD Histogram 0.3199
Fundamentals Value
Market Cap 244.11 Million
Num Shares 35.7 Million
EPS -2.11
Price-to-Earnings (P/E) Ratio -3.24
Price-to-Sales 116.65
Price-to-Book 0.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.73
Resistance 3 (R3) 7.81 7.60 7.58
Resistance 2 (R2) 7.60 7.37 7.56 7.53
Resistance 1 (R1) 7.22 7.24 7.12 7.14 7.48
Pivot Point 7.01 7.01 6.96 6.97 7.01
Support 1 (S1) 6.63 6.78 6.53 6.55 6.20
Support 2 (S2) 6.42 6.65 6.38 6.15
Support 3 (S3) 6.04 6.42 6.10
Support 4 (S4) 5.96